AIIMS Panel Gives Nod for Covaxin Human Trials

The Ethics Committee of the All India Institute of Medical Sciences (AIIMS) has given the approval to start the human trials for the indigenously developed COVID 19 vaccine, Covaxin. The premier hospital is expected to start the trial from July 20 on healthy volunteers. AIIMS New Delhi is one of the 12 sites designated by ..